Cargando…

Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC‐HFT Trials

Transendocardial stem cell injection in patients with ischemic cardiomyopathy (ICM) improves left ventricular function and structure but has ill‐defined effects on ventricular arrhythmias. We hypothesized that mesenchymal stem cell (MSC) implantation is not proarrhythmic. Post hoc analyses were perf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramireddy, Archana, Brodt, Chad R., Mendizabal, Adam M., DiFede, Darcy L., Healy, Chris, Goyal, Vishal, Alansari, Yahya, Coffey, James O., Viles‐Gonzalez, Juan F., Heldman, Alan W., Goldberger, Jeffrey J., Myerburg, Robert J., Hare, Joshua M., Mitrani, Raul D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Translational Research Articles and Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442721/ https://www.ncbi.nlm.nih.gov/pubmed/28252842 http://dx.doi.org/10.1002/sctm.16-0328

Ejemplares similares

Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
por: Rieger, Angela C., et al.
Publicado: (2019)

Proarrhythmia Induced by Propafenone: What is the Mechanism?
por: Femenia, Francisco, et al.
Publicado: (2010)

Transgenic Rabbit Models in Proarrhythmia Research
por: Baczkó, István, et al.
Publicado: (2020)

Proarrhythmia and Oncotherapy: So Much To Be Done!
por: Kovacs, Richard J.
Publicado: (2021)

B-PO04-152 RISK OF SUDDEN CARDIAC DEATH IN COMPETITIVE ATHLETES DURING THE CONVALESCENT PHASE FOLLOWING COVID-19 INFECTION
por: Mitrani, Raul D., et al.
Publicado: (2021)

Transendocardial, autologous bone-marrow cell transplant in severe, chronic ischemic heart failure
por: Dohman, HF, et al.
Publicado: (2003)

Transendocardial CD34(+) Cell Transplantation in Noncompaction Cardiomyopathy: First-in-Man Case Study
por: Cerar, Andraz, et al.
Publicado: (2018)

Long-term cardiac surveillance and outcomes of COVID-19 patients
por: Mitrani, Raul D., et al.
Publicado: (2022)

Management Strategies for POSEIDON's Group 1
por: Polyzos, Nikolaos P., et al.
Publicado: (2019)

Management Strategies for POSEIDON Group 2
por: Sunkara, Sesh Kamal, et al.
Publicado: (2020)

Proarrhythmia in a Patient With Heart Failure on Therapy With Amiodarone
por: Semerdzhieva, Niya E, et al.
Publicado: (2021)

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia
por: Uddin, Muhammad Erfan, et al.
Publicado: (2022)

Effects of Transendocardial CD34(+) Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy
por: Bervar, Mojca, et al.
Publicado: (2017)

Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease
por: Golpanian, Samuel, et al.
Publicado: (2016)

Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
por: Golpanian, Samuel, et al.
Publicado: (2016)

POSEIDON: The secrets of the Trident Node monitoring tool
por: Kuffo Rivero, Leonardo Xavier
Publicado: (2018)

Management Strategies for POSEIDON Groups 3 and 4
por: Haahr, Thor, et al.
Publicado: (2019)

Transendocardial CD34(+) Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy
por: Žorž, Neža, et al.
Publicado: (2022)

Early Drug Discovery Prediction of Proarrhythmia Potential and Its Covariates
por: Polak, Sebastian, et al.
Publicado: (2015)

Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
por: Dutta, Sara, et al.
Publicado: (2017)

Tic-tac sans tac-tic
Publicado: (1999)

Catheter-based transendocardial delivery of autologous bone marrow-derived mononuclear cells in patients listed for heart transplantation
por: Dohmann, HF, et al.
Publicado: (2003)

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2019)

Assessment of drug-induced proarrhythmias due to pilsicainide in patients with atrial tachyarrhythmias
por: Koike, Hideki, et al.
Publicado: (2016)

Necessity to evaluate PI3K/Akt signalling pathway in proarrhythmia
por: Ezeani, Martin, et al.
Publicado: (2017)

Corrigendum: Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
por: Dutta, Sara, et al.
Publicado: (2017)

The Role of the Food and Drug Administration in Drug Development: On the Subject of Proarrhythmia Risk
por: Thind, Munveer, et al.
Publicado: (2020)

Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
por: Humaidan, Peter, et al.
Publicado: (2019)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Bühler, Klaus F.
Publicado: (2020)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Fischer, Robert, et al.
Publicado: (2020)

Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency
por: van der Spoel, Tycho IG, et al.
Publicado: (2012)

A pilot prospective cohort study using experimental quantification of early peripheral nerve regeneration with high-frequency three-dimensional tomographic ultrasound (HFtUS)
por: Murphy, Ralph N. A., et al.
Publicado: (2023)

An unusual form of TAC–TAC sine autonomic phenomena
por: Pugach, Neil Lewis
Publicado: (2008)

Right ventricular lead proarrhythmia: A novel intervention for an under-recognized phenomenon
por: Hayase, Justin, et al.
Publicado: (2017)

Uncertainty assessment of proarrhythmia predictions derived from multi-level in silico models
por: Kopańska, Karolina, et al.
Publicado: (2023)

ICD discrimination of SVT versus VT with 1:1 V-A conduction: A review of the literature
por: Cardoso, Rhanderson N., et al.
Publicado: (2016)

Utility of exercise testing to assess athletes for post COVID-19 myocarditis()
por: Mitrani, R.D., et al.
Publicado: (2022)

Automated Algorithm for J-T(peak) and T(peak)-T(end) Assessment of Drug-Induced Proarrhythmia Risk
por: Johannesen, Lars, et al.
Publicado: (2016)

Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
por: Li, Zhihua, et al.
Publicado: (2018)

Effect of hydroxychloroquine on proarrhythmia risk assessment using human iPSC-derived cardiomyocytes
por: Yanagida, Shota, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3itjcd5nlu092s4o5a04v35r85